DUBLIN--(BUSINESS WIRE)--The "Hong Kong Wound Dressing Market Research Report: By Type, Application, End User, Distribution Channel - Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The Hong Kong wound care market is predicted to reach a value of $80.7 million by 2030, rising from $46.0 million in 2019, progressing at a 5.4% CAGR during the forecast period (2020-2030).

The key factors leading to the growth of the market are the increasing incidence of traumatic injuries, surging prevalence of diabetes, and rising geriatric population. The market is bifurcated into traditional and advanced, on the basis of type.

Between these two, the advanced bifurcation held the larger revenue share of the market in 2019, as advanced wound care products aid in accelerating the wound healing process and further provide patients with convenience. In addition to this, these wound care products have the advantage of forming part of the natural tissue matrix. The increasing prevalence of chronic diseases across the globe is also driving the demand for advanced wound care products. The bifurcation is further divided into wound therapy devices, wound dressings, and wound care biologics.

In terms of application, the Hong Kong wound care market is categorized into acute wounds and chronic wounds, between which, the chronic wound category held the major share of the market in 2019. The category is further projected to grow at a faster pace during the forecast period, owing to the surging incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Chronic wounds need frequent and more-efficient dressing for their management, which is leading to the growth of the market.

The rapidly increasing prevalence of diabetes is also a major factor resulting in the growth of the Hong Kong wound care market. As per the Centre for Health Protection, which is an agency under the Department of Health of Hong Kong, in 2017, diabetes was the major cause of mortality and morbidity in the metropolis. Diabetic patients are highly susceptible to developing wounds, and the wound healing process is further slowed down because of diabetes, which creates high demand for wound care products.

In conclusion, the market is growing due to the increasing prevalence of traumatic injuries and rising incidence of diabetes in Hong Kong.

Key Topics Covered:

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Baseline Methodology

2.4 Market Size Estimation

2.5 Data Triangulation

2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Market Definition

4.1.1 By Type

4.1.1.1 Advanced

4.1.1.1.1 Foam

4.1.1.1.2 Hydrocolloid

4.1.1.1.3 Film

4.1.1.1.4 Alginate

4.1.1.1.5 Antimicrobial

4.1.1.1.6 Hydrogel

4.1.1.1.7 Collagen

4.1.1.1.8 Hydrofiber

4.1.1.1.9 Wound contact layer

4.1.1.1.10 Superabsorbent

4.1.1.1.11 NPWT

4.1.1.1.12 Others

4.1.1.2 Traditional

4.1.1.2.1 Bandages

4.1.1.2.2 Gauzes

4.1.1.2.3 Sponges

4.1.1.2.4 Abdominal pads

4.1.1.2.5 Others

4.1.2 By Application

4.1.2.1 Chronic wounds

4.1.2.1.1 DFUs

4.1.2.1.2 VLUs

4.1.2.1.3 Pressure ulcers

4.1.2.1.4 Others

4.1.2.2 Acute wounds

4.1.2.2.1 Surgical and traumatic wounds

4.1.2.2.2 Burns

4.1.3 By End User

4.1.3.1 Hospitals and specialty clinics

4.1.3.1.1 Inpatient settings

4.1.3.1.2 Outpatient settings

4.1.3.2 Home healthcare

4.1.3.3 Long-term care settings

4.1.4 By Distribution Channel

4.1.4.1 Pharmacies

4.1.4.2 Online channels

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Shift in preference from traditional products to advanced therapies

4.2.2 Drivers

4.2.2.1 Growing geriatric population

4.2.2.2 Increasing prevalence of diabetes

4.2.2.3 High incidence of traumatic injuries

4.2.2.4 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of advanced wound dressing products

4.2.3.2 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Improving economy and increasing health expenditure

4.2.4.2 Ineffectiveness of traditional wound dressings in acute wound management

4.3 Impact of COVID-19

4.4 Porter's Five Forces Analysis

4.5 Regulatory Overview

4.6 Wound Dressing Product Pricing

Chapter 5. Epidemiology of Wounds in Hong Kong

5.1 Total Incidence of Wounds

5.2 Incidence of Wounds, By Type

5.2.1 Incidence of Acute Wounds, by type

5.2.2 Incidence of Chronic Wounds, by Type

Chapter 6. Hong Kong Market Size and Forecast

6.1 By Type

6.1.1 Advanced Wound Dressing Market, by Type

6.1.1.1 Foam dressing market

6.1.1.2 Hydrocolloid dressing market

6.1.1.3 Film dressing market

6.1.1.4 Alginate dressing market

6.1.1.5 Antimicrobial dressing market

6.1.1.6 Hydrogel dressing market

6.1.1.7 Collagen dressing market

6.1.1.8 Hydrofiber dressing market

6.1.1.9 Wound contact layers dressing market

6.1.1.10 Superabsorbent dressing market

6.1.1.11 NPWT dressing market

6.1.2 Traditional Wound Dressing Market, by Type

6.2 By Application

6.2.1 Wound Dressing Market for Chronic Wounds, by Type

6.2.2 Wound Dressing Market for Acute Wounds, by Type

6.3 By End User

6.3.1 Wound Dressing Market in Hospitals and Specialty Clinics, by Type

6.4 By Distribution Channel

Chapter 7. Competitive Landscape

7.1 Revenue Share Analysis of Major Companies

7.1.1 3M Company

7.1.2 ConvaTec Group Plc

7.1.3 Coloplast A/S

7.1.4 PAUL HARTMANN Asia-Pacific Ltd.

7.1.5 Winner Medical Co. Ltd.

7.1.6 Molnlycke Health Care AB

7.1.7 Smith & Nephew plc

7.2 Advanced Wound Dressings Usage Share Analysis, By Hospital

7.2.1 Government Hospitals

7.2.1.1 Tuen Mun Hospital (TMH)

7.2.1.2 United Christian Hospital (UCH)

7.2.1.3 Queen Elizabeth Hospital (QEH)

7.2.1.4 Prince of Wales Hospital (PWH)

7.2.1.5 Pamela Youde Nethersole Eastern Hospital (PYNEH)

7.2.1.6 Princess Margaret Hospital (PMH)

7.2.1.7 Queen Mary Hospital (QMH)

7.2.2 Private Hospitals

7.2.2.1 Evangel Hospital

7.2.2.2 Gleneagles Hong Kong Hospital

7.2.2.3 Hong Kong Adventist Hospital

7.2.2.4 Hong Kong Baptist Hospital

7.2.2.5 Hong Kong Sanatorium & Hospital Limited

7.2.2.6 Matilda & War Memorial Hospital

7.2.2.7 Precious Blood Hospital

7.2.2.8 St. Paul's Hospital

7.2.2.9 St. Teresa's Hospital

7.2.2.10 Union Hospital

7.2.2.11 Canossa Hospital

7.3 Strategic Developments of Key Players

7.3.1 Mergers and Acquisitions

7.3.2 Partnerships

7.3.3 Other Developments

Chapter 8. Company Profiles

• Coloplast A/S
• 3M Company
• Paul Hartmann AG
• Winner Medical Co. Ltd.
• Molnlycke Health Care AB
• Smith & Nephew PLC
• ConvaTec Group PLC
• Allmed Medical Products Co. Ltd.
• Zhende Medical Co. Ltd.
• Wayson Medical Co. Ltd.
• B. Braun Melsungen AG
• BSN medical GmbH
• Beiersdorf AG
• Johnson & Johnson
• Urgo Medical
• Cardinal Health Inc.
• Medtronic plc
• Integra LifeSciences Holdings Corporation
• Wright Medical Group N.V.
• Medela AG
• Lohmann & Rauscher GmbH & Co. KG
• Nitto Denko Corporation
• Weigao Group Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/4ondqm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900